ES2110101T3 - Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa. - Google Patents
Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa.Info
- Publication number
- ES2110101T3 ES2110101T3 ES93915230T ES93915230T ES2110101T3 ES 2110101 T3 ES2110101 T3 ES 2110101T3 ES 93915230 T ES93915230 T ES 93915230T ES 93915230 T ES93915230 T ES 93915230T ES 2110101 T3 ES2110101 T3 ES 2110101T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- aryl
- halosubstituted
- alkoxy
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
CIERTOS NUEVOS DERIVADOS DEL INDOL TIENEN LA HABILIDAD DE INHIBIR LA ENZIMA DE 5-LIPOXIGENASA Y TIENEN LA FORMULA (I) EN DONDE R1 ES ALQUILO C1-C4 O -NR2R3; R2 Y R3 SON CADA UNO INDEPENDIENTEMENTE, HIDROGENO O ALQUILO C1-C4; R4 ES CICLOALQUILO C3-C6, CICLOALQUILALQUILO C4-C7, ALQUILO C2-C4 ARILOXI, ALQUILO C2-C4 ARILTIO, ALQUILO C2-C4 ARILAMINO, ALQUILO C2-C4 ARILSULFINILO, ARILO, ALQUILO C1-C6 ARILO, ALQUILO C1-C6 ARILOXIARILO O ALQUILO C1-C6 ARILTIOARILO, Y LOS GRUPOS ARILO EN DICHO ARILOXIALQUILO, ARILTIOALQUILO, ALRILAMINOALQUILO, ARILSULFINILALQUILO, ARILO, ARILALQUILO, ARILOXIARILALQUILO Y ARILTIOARILALQUILO PODRIAN SER SUSTITUIDOS HASTA EN NUMERO MAXIMO DE SUSTITUYENTES Y LOS SUSTITUYENTES CADA UNO INDEPENDIENTEMENTE, SON SELECCIONADOS DEL GRUPO QUE CONSISTE EN HALO, CIANO, ALQUILO C1-C5, ALQUENILO C2-C6, ALCOXI C1-C5, ALQUENILOXI C2-C6, ALCOXIALQUILO C2-C6, ALQUILO C1-C4 HALOSUSTITUIDO, ALCOXI C1-C4 HALOSUSTITUIDO, ALCOXICARBONILO C2-C5, AMINOCARBONILO Y ALQUILTIO C1-C4; A ES ALQUILENO C1-C6, ALQUENILENO C3-C6 O -O-(CH2)M-; Y ES INDEPENDIENTEMENTE, HALOGENO, ALQUILO C1-C6 HALOSUSTITUIDO, ALQUILO C1-C6, ALQUENILO C2-C6, ALCOXI C1-C6 O ALQUENILOXI C3-C8; M ES 2, 3 O 4; N ES 0, 1, 2 O 3; Y SIEMPRE QUE EL SUSTITUYENTE Y, SI ESTA PRESENTE, Y EL GRUPO A ENLAZANTE ESTEN UNIDOS AL ANILLO AROMATICO. ESTOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ALIVIACION DE ENFERMEDADES INFLAMATORIAS, CONDICIONES ALERGICAS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS Y COMO INGREDIENTE ACTIVO EN COMPOSICIONES FARMACEUTICAS PARA TRATAR TALES CONDICIONES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4197242A JP2661841B2 (ja) | 1992-07-23 | 1992-07-23 | インドリン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2110101T3 true ES2110101T3 (es) | 1998-02-01 |
Family
ID=16371216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93915230T Expired - Lifetime ES2110101T3 (es) | 1992-07-23 | 1993-06-10 | Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa. |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0651743B1 (es) |
| JP (1) | JP2661841B2 (es) |
| KR (1) | KR950702533A (es) |
| CN (1) | CN1085894A (es) |
| AT (1) | ATE161250T1 (es) |
| AU (1) | AU675654B2 (es) |
| BR (1) | BR9306762A (es) |
| CA (1) | CA2140344C (es) |
| CZ (1) | CZ15995A3 (es) |
| DE (1) | DE69315841T2 (es) |
| DK (1) | DK0651743T3 (es) |
| ES (1) | ES2110101T3 (es) |
| FI (1) | FI104068B1 (es) |
| GR (1) | GR3025809T3 (es) |
| HU (1) | HUT70182A (es) |
| IL (1) | IL106359A0 (es) |
| MX (1) | MX9304441A (es) |
| NZ (1) | NZ253881A (es) |
| PL (1) | PL307229A1 (es) |
| SK (1) | SK8695A3 (es) |
| TW (1) | TW227556B (es) |
| WO (1) | WO1994002459A1 (es) |
| YU (1) | YU50893A (es) |
| ZA (1) | ZA935304B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8870191A (en) * | 1990-10-02 | 1992-04-28 | Stat-Tech International Corporation | Electric charge discharge and dissipation device |
| AU4400597A (en) * | 1996-10-08 | 1998-05-05 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
| US5952322A (en) * | 1996-12-05 | 1999-09-14 | Pfizer Inc. | Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors |
| EP1101492A4 (en) * | 1998-07-17 | 2002-09-25 | Daiichi Fine Chem Co Ltd | MEDICINE AGAINST ALLERGIC DISEASES |
| EP1283199A4 (en) * | 2000-05-16 | 2003-12-17 | Takeda Chemical Industries Ltd | MELANIN CONCENTRATION HORMONE ANTAGONIST |
| UA95084C2 (en) * | 2005-11-04 | 2011-07-11 | Амира Фармасутикалз, Инк. | 5-lipoxygenase-activating protein (flap) inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0279263B1 (en) * | 1987-02-10 | 1993-08-04 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| IE903206A1 (en) * | 1989-09-07 | 1991-03-13 | Abbott Lab | Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds |
| KR900016822A (ko) * | 1990-04-20 | 1990-11-14 | 하라 레이노스께 | 슬라이드 프로젝터 |
| US5132319A (en) * | 1991-03-28 | 1992-07-21 | Merck Frosst Canada, Inc. | 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis |
-
1992
- 1992-07-23 JP JP4197242A patent/JP2661841B2/ja not_active Expired - Fee Related
-
1993
- 1993-06-10 PL PL93307229A patent/PL307229A1/xx unknown
- 1993-06-10 EP EP93915230A patent/EP0651743B1/en not_active Expired - Lifetime
- 1993-06-10 AU AU45291/93A patent/AU675654B2/en not_active Expired - Fee Related
- 1993-06-10 AT AT93915230T patent/ATE161250T1/de not_active IP Right Cessation
- 1993-06-10 CA CA002140344A patent/CA2140344C/en not_active Expired - Fee Related
- 1993-06-10 SK SK86-95A patent/SK8695A3/sk unknown
- 1993-06-10 DK DK93915230.2T patent/DK0651743T3/da active
- 1993-06-10 BR BR9306762A patent/BR9306762A/pt not_active Application Discontinuation
- 1993-06-10 NZ NZ253881A patent/NZ253881A/en unknown
- 1993-06-10 DE DE69315841T patent/DE69315841T2/de not_active Expired - Fee Related
- 1993-06-10 CZ CZ95159A patent/CZ15995A3/cs unknown
- 1993-06-10 WO PCT/US1993/005391 patent/WO1994002459A1/en active IP Right Grant
- 1993-06-10 ES ES93915230T patent/ES2110101T3/es not_active Expired - Lifetime
- 1993-06-12 TW TW082104672A patent/TW227556B/zh active
- 1993-07-15 IL IL106359A patent/IL106359A0/xx unknown
- 1993-07-22 HU HU9302126A patent/HUT70182A/hu unknown
- 1993-07-22 ZA ZA935304A patent/ZA935304B/xx unknown
- 1993-07-22 FI FI933307A patent/FI104068B1/fi not_active IP Right Cessation
- 1993-07-22 CN CN93108985A patent/CN1085894A/zh active Pending
- 1993-07-22 MX MX9304441A patent/MX9304441A/es unknown
- 1993-07-22 YU YU50893A patent/YU50893A/sh unknown
-
1994
- 1994-01-25 KR KR1019940700233A patent/KR950702533A/ko not_active Application Discontinuation
-
1997
- 1997-12-30 GR GR970403456T patent/GR3025809T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ253881A (en) | 1996-01-26 |
| PL307229A1 (en) | 1995-05-15 |
| BR9306762A (pt) | 1998-12-08 |
| ATE161250T1 (de) | 1998-01-15 |
| FI933307A (fi) | 1994-01-24 |
| HU9302126D0 (en) | 1993-10-28 |
| HUT70182A (en) | 1995-09-28 |
| EP0651743A1 (en) | 1995-05-10 |
| FI104068B (fi) | 1999-11-15 |
| YU50893A (sh) | 1996-07-24 |
| KR950702533A (ko) | 1995-07-29 |
| DK0651743T3 (da) | 1998-02-02 |
| GR3025809T3 (en) | 1998-03-31 |
| FI104068B1 (fi) | 1999-11-15 |
| CA2140344C (en) | 1997-08-26 |
| AU675654B2 (en) | 1997-02-13 |
| CA2140344A1 (en) | 1994-02-03 |
| WO1994002459A1 (en) | 1994-02-03 |
| CN1085894A (zh) | 1994-04-27 |
| ZA935304B (en) | 1995-01-23 |
| MX9304441A (es) | 1994-07-29 |
| JPH0641068A (ja) | 1994-02-15 |
| DE69315841D1 (de) | 1998-01-29 |
| EP0651743B1 (en) | 1997-12-17 |
| IL106359A0 (en) | 1993-11-15 |
| DE69315841T2 (de) | 1998-04-09 |
| AU4529193A (en) | 1994-02-14 |
| TW227556B (es) | 1994-08-01 |
| CZ15995A3 (en) | 1995-09-13 |
| JP2661841B2 (ja) | 1997-10-08 |
| FI933307A0 (fi) | 1993-07-22 |
| SK8695A3 (en) | 1995-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015448D0 (no) | Kinolinderivater som inhibitorer av MEK enzymer | |
| NO20015446L (no) | Kinolin-derivater som inhibitorer for MEK-enzymer | |
| HUT62264A (en) | Process for producing amidino compounds and pharmaceutical compositions comprising same as active ingredient | |
| ES2110101T3 (es) | Derivados de indolinil n-hidroxiurea y acido n-hidroxamico como inhibidores de lipoxigenasa. | |
| ATE113942T1 (de) | Lipoxygenase inhibierende hydroxamsäure und n- hydroxyharnstoff-derivate. | |
| ATE215075T1 (de) | Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend | |
| DE69207597D1 (de) | Lipoxygenase inhibierende tetrahydrobenzazepinderivate | |
| NO20004679L (no) | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse | |
| DK0588850T3 (da) | N-hydroxyureaderivater, som inhiberer lipoxygenase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 651743 Country of ref document: ES |